资讯

Palo Alto Networks Inc. proved the skeptics wrong with its fourth-quarter earnings on Monday, signaling potential green shoots for the underperforming cybersecurity sector. Palo Alto impressed ...
Dallas Wings' star guard Paige Bueckers poured in a career-high 44 points on 81 percent shooting Wednesday night. The stellar performance cemented the reigning No. 1 overall draft pick as the first ...
Dallas Wings' star rookie Paige Bueckers has impressed thus far in 2025, tallying over 18 points, four rebounds and five assists per contest in her WNBA debut season. Read more: Sparks' Cameron Brink ...
WASHINGTON — Sonia Citron tied her career high with five three-pointers and finished with 24 points, Kiki Iriafen added 18 points and 10 rebounds and the Washington Mystics beat the Sparks 95-86 on ...
A shocking post to the subreddit r/ThriftGrift revealed out-of-place high prices for knick-knacks at a Goodwill. "This is getting ridiculous," the OP wrote, along with images of somewhat shabby ...
President Bola Ahmed Tinubu’s appointment of Mr Peter Ogbonna Eze as the Federal Character Commission (FCC) Commissioner representing Enugu State has drawn widespread commendation from political ...
One of the ugliest buildings in Reno-Sparks could be replaced. The other has remained a community staple since 2000. Reno is full of historic buildings that recall the Old West and the city’s role in ...
LOS ANGELES (AP) — Kelsey Plum banked in the winning shot just before the final buzzer and the Los Angeles Sparks beat the Dallas Wings 81-80 on Wednesday night to spoil rookie Paige Bueckers' ...
The rural Otter Tail County widow of Sam Long sent a letter to her senator, after her husband’s suicide. Leading to a $1.5 million pilot mental health program in Minnesota. Sam Long's suicide in ...
DENVER (KDVR) — Another fire has sparked in Rio Blanco County, where over 130,000 acres of land have burned in recent weeks. In Rio Blanco County, the Lee Fire has grown over 116,000 acres and is now ...
In the final clip, James D. Chalmers, MBChB, PhD, notes that while the FDA approval of brensocatib is a milestone, questions remain on optimal patient selection, long-term benefits, and further ...